Five9 Inc
For the period ended Dec 31, 2024. Filed Feb 21, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 21, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Consolidated Financial Statements
- Description of Business and Summary of Significant Accounting Policies
Five9, Inc. and its wholly-owned subsidiaries (the “Company”) is a provider of cloud software for contact centers. The Company was incorporated in Delaware in 2001 and is headquartered in San Ramon, California. The Company has offices in Europe, Asia and Australia, which primarily provide research, development, sales, marketing, and customer support services.
Basis of Presentation
The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding annual financial reporting. All intercompany transactions and balances have been eliminated in consolidation.
Use of Estimates
The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The significant estimates made by management affect revenue and related reserves, as well as the fair value of assets acquired and liabilities assumed through business combinations. Management periodically evaluates such estimates and they are adjusted prospectively based upon such periodic evaluation. Actual results could differ from those estimates.
Foreign Currency
The functional currency of the Company’s foreign subsidiaries is the U.S. dollar. For these subsidiaries, the monetary assets and liabilities resulting from foreign currency transactions are adjusted to reflect the exchange rate as of the balance sheet date. Foreign currency transaction gains and losses were not significant in any period and are reported in “Other income (expense), net” in the consolidated statements of operations and comprehensive loss.
Cash and Cash Equivalents
The Company’s cash and cash equivalents consist of highly liquid investments with maturities of three months or less at the time of purchase. The Company’s cash equivalents consist of investments in money market funds and U.S. treasury securities.
Marketable Investments
The Company’s marketable investments consist of U.S. treasury securities, U.S. agency securities and government sponsored securities, certificates of deposit, corporate bonds, and commercial paper. The Company’s marketable investments are classified as available-for-sale and carried at fair value. The intent is that all marketable investments are available for use in the Company’s current operations, including marketable investments with maturity dates greater than one year from December 31, 2024. The Company monitors its available-for-sale debt securities for potential impairment on a quarterly basis. If the Company intends to sell a debt security or it is more likely than not that the Company will be required to sell the security before recovery, then a decline in fair value below cost is recorded as an impairment charge in interest income and other in the consolidated statements of operations. In other cases, the Company further assesses whether the decline in fair value below cost is due to credit or non-credit related factors. Any credit-related unrealized losses are recognized as an allowance on the consolidated balance sheets with a corresponding charge in interest income and other in the consolidated statements of operations and comprehensive loss. Non-credit related unrealized losses and unrealized gains on available-for-sale debt securities are included in accumulated other comprehensive income.
Concentration Risks
Financial instruments, which potentially subject the Company to significant concentrations of credit risk, consist primarily of cash and cash equivalents, marketable investments and accounts receivable. A significant portion of the Company’s cash and cash equivalents is held atthree large reputable financial institutions. Total cash and cash equivalents in excess of insured limits were $360.2 million and $141.1 million as of December 31, 2024 and 2023, respectively. The Company has not experienced any losses in such accounts.
As of December 31, 2024, there was no customer that represented more than 10% of accounts receivable. As of December 31, 2023, there was one customer which represented 11% of accounts receivable. For the years ended December 31, 2024, 2023 and 2022, no single customer represented more than 10% of revenue.
Provision for Credit Losses
The Company uses an expected credit loss model, which requires it to consider historical loss rates and expectations of forward-looking losses to estimate its provision for credit losses on its trade accounts receivables, unbilled accounts receivables and contract assets.
The following table presents the changes in the provision for credit losses (in thousands):
| Year Ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Balance, beginning of period | $264 | $262 |
| Add: bad debt expense | 1,150 | 989 |
| Less: write-offs, net of recoveries | (1,073) | (987) |
| Balance, end of period | $341 | $264 |
Property and Equipment, Net
Property and equipment is stated at cost less accumulated depreciation and amortization, and is depreciated using the straight-line method over the estimated useful lives of the assets as follows:
| Asset Category | Estimated Useful Lives |
|---|---|
| Computer and network equipment | 3 to 5 years |
| Computer software | 3 years |
| Internal-use software development costs | 3 years |
| Furniture and fixtures | 7 years |
| Leasehold improvements | Shorter of useful life or lease term |
The Company capitalizes certain qualifying costs incurred during the development stage of internal-use software. Costs related to preliminary project activities and post-implementation activities are expensed in research and development as incurred. Preliminary project activities include conceptual formulation, evaluation and final selection of alternatives, planning, proof of concept and requirement analysis of the selected alternative. The post- implementation stage begins when the internal-use software is ready for its intended use, and includes all internal and external training and application maintenance activities. Capitalized internal-use software development costs are included within property and equipment, net on the consolidated balance sheets, and are amortized over the estimated useful life of the software, which isthree years. The related amortization expense is recognized in cost of revenue in the consolidated statements of operations and comprehensive loss.
Maintenance and repairs of property and equipment are charged to expense as incurred, and improvements and betterments are capitalized. When assets are retired or otherwise disposed of, the cost and accumulated depreciation and amortization are removed from the consolidated balance sheet and any resulting gain or loss is reflected in the consolidated statements of operations and comprehensive loss in the period realized.
The Company evaluates the recoverability of property and equipment for possible impairment whenever events or circumstances indicate that the carrying amount of such assets or asset groups may not be recoverable. Recoverability of these assets is measured by a comparison of the carrying amounts to the future undiscounted cash flows the assets or asset groups are expected to generate. If such evaluation indicates that the carrying amount of the assets or asset groups is not recoverable, the carrying amount of such assets or asset groups is reduced to fair value. During 2024, the Company recognized impairment losses recorded in general and administrative expenses of $1.9 million as a result of its commitment to closetwo operating lease facilities and $0.3 million related to the associated leasehold improvements and property and equipment.
Business Combinations
The Company uses its best estimates and assumptions to assign fair value to the tangible and intangible assets acquired and liabilities assumed as of the acquisition date. The Company’s estimates are inherently uncertain and subject to change. During the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments to the fair value of these tangible and intangible assets and liabilities assumed, with the corresponding offset to goodwill. In addition, uncertain tax positions and tax-related valuation allowances are initially established in connection with a business combination as of the acquisition date. Upon the conclusion of the measurement period or final determination of the fair value of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the consolidated statements of operations and comprehensive loss.
Goodwill and Intangible Assets
The Company records goodwill when the consideration paid in a business combination exceeds the fair value of the net tangible assets and the identified intangible assets acquired. Goodwill is not amortized, but instead is required to be tested for impairment annually and whenever events or changes in circumstances indicate that the carrying value of goodwill may exceed its fair value.
The Company performs testing for impairment of goodwill in its fourth quarter, or as events occur or circumstances change that would more likely than not reduce the fair value of the Company’s single reporting unit below its carrying amount. A qualitative assessment is first made to determine whether it is necessary to perform the quantitative goodwill impairment test. This initial qualitative assessment includes, among other things, consideration of: (i) market capitalization of the Company; (ii) past, current and projected future earnings and equity; (iii) recent trends and market conditions; and (iv) valuation metrics involving similar companies that are publicly-traded and acquisitions of similar companies, if available. If this initial qualitative assessment indicates that it is more likely than not that impairment exists, a second quantitative assessment will be performed, involving a comparison between the estimated fair values of the Company’s single reporting unit with its respective carrying amount including goodwill. If the carrying value exceeds estimated fair value, an impairment charge is recorded for the excess. The Company may elect to bypass the qualitative assessment and proceed to perform the quantitative goodwill impairment test.
Intangible assets, consisting of acquired developed technology, trademarks and customer relationships, are carried at cost less accumulated amortization. All intangible assets have been determined to have definite lives and are amortized on a straight-line basis over their estimated remaining economic lives, ranging from three toeight years. Amortization expense related to developed technology is included in cost of revenue. Amortization expense related to customer relationships is included in sales and marketing expense. Amortization expense related to domain names is included in general and administrative expense. Intangible assets are reviewed for impairment whenever events or changes in circumstances indicate an asset’s carrying value may not be recoverable.
Revenue Recognition
Revenue is recognized when control of the promised services is transferred to customers in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company generates all of its revenue from contracts with customers. In contracts with multiple performance obligations, it identifies each performance obligation and evaluates whether the performance obligations are distinct within the context of the contract at contract inception. Performance obligations that are not distinct at contract inception are combined. The Company allocates the transaction price to each distinct performance obligation proportionately based on the estimated standalone selling price for each performance obligation. The Company then looks to how services are transferred to the customer in order to determine the timing of revenue recognition. Most services provided under the Company’s agreements result in the transfer of control over time.
The Company’s revenue consists of subscription services and related usage as well as professional services. The Company charges customers monthly subscription fees for access to its Intelligent CX Platform, primarily based on the number of licenses, as well as on a consumption or capacity basis for its AI solutions. Licenses are defined as the maximum number of named agents allowed to concurrently access the Intelligent CX Platform. Customers typically have more named agents than licenses. Multiple named agents may use a license, though not simultaneously. The majority of the Company’s customers purchase both subscriptions and related telephony usage. A growing number of the Company’s customers subscribe to its platform but purchase telephony usage directly from a wholesale telecommunications service provider. The Company does not sell telephony usage on a stand-alone basis to any customer. The related usage fees are generally based on the volume of minutes used for inbound and outbound client interactions. Revenue generated from telephony usage is presented in revenue and cost of sales on a gross basis, as the Company is the party that controls the service and is responsible for fulfilling the promise to provide the call service by diverting the calls to selected carriers. The Company also offers bundled plans, generally for smaller deployments, whereby the customer is charged a single monthly fixed fee per agent seat that includes both subscription and unlimited usage in the contiguous 48 states and, in some cases, Canada. Professional services revenue is derived primarily from Intelligent CX implementations, including application configuration, system integration, optimization, education and training services. Customers are not permitted to take possession of the Company’s software.
The Company offers monthly, annual and multiple-year contracts to its customers, generally with 30 days’ notice required for limited reductions in the number of licenses or the level of consumption or capacity. Increases in the number of licenses or the level of consumption or capacity can be provisioned almost immediately. The Company’s customers, therefore, are able to adjust the number of licenses used to meet their changing contact center needs. The Company’s larger customers typically choose annual contracts, which generally include an implementation and ramp period of several months. Subscription fees, including bundled plans, are generally billed monthly in advance, while related usage fees are billed in arrears. Support activities include technical assistance for the Company’s solution and upgrades and enhancements to the Intelligent CX Platform on a when-and-if-available basis, which are not billed separately.
The Company generally requires advance deposits from its customers based on estimated usage when such usage is not billed as part of a bundled plan. Any unused portion of the deposit is refundable to the customer upon termination of the arrangement, provided all amounts due have been paid. All fees, except usage deposits, are non-refundable.
Professional services are primarily billed on a fixed-fee basis and are performed by us directly. However, our customers can choose to perform these services themselves, use one of the Company’s certified professional service providers, or engage their own third-party service providers. Revenue for professional services is recognized over time, as services are performed.
The estimation of variable consideration for each performance obligation requires the Company to make subjective judgments resulting in estimated variable consideration that is included in the transaction fee. This is done to the extent that it is probable, in the Company’s judgment, that a significant reversal in the amount of cumulative revenue recognized under the contract will not occur. The Company estimates the variable consideration in order to allocate the overall transaction fee on a relative stand-alone selling price basis to its multiple performance obligations. When services are included in the contract with the customer and are not sold at their stand-alone selling price, the Company is required to estimate the number of agents the customer will use, especially during the initial ramp period of the contract, during which the Company bills under an ‘actual usage’ model for subscription-related services. To date, variable consideration has not had a material impact on the allocation of transaction fees to multiple performance obligations.
The Company recognizes revenue on fixed fee professional services performance obligations based on the proportion of labor hours expended compared to the total hours expected to complete the related performance obligation. The determination of the total labor hours expected to complete the performance obligations involves judgment, which influences the initial stand-alone selling price estimate as well as the timing of professional services revenue recognition, although this is typically resolved in a short time frame.
When a contract with a customer is signed, the Company assesses whether collection of the fees under the arrangement is probable. The Company assesses collection based on a number of factors, including past transaction history and the creditworthiness of the client. The Company maintains a revenue reserve for potential credits to be issued in accordance with service level agreements or for other revenue adjustments.
Deferred Revenue
Deferred revenue consists of billings or payments received from customers for subscription services, usage and professional services in advance of revenue recognition and is recognized in accordance with the Company’s revenue recognition policy discussed above. The Company generally invoices its customers monthly in advance for subscription services. Accordingly, the deferred revenue balance does not represent the total contract value of sales arrangements.
Cost of revenue consists primarily of personnel costs, including stock-based compensation, fees that the Company pays to telecommunications providers for usage, USF contributions and other regulatory costs, depreciation and related expenses of servers and equipment, costs to build out and maintain co-location data centers, costs of public cloud-based data centers, cost of third party software that the Company resells, allocated office and facility costs, amortization of acquired technology and amortization of internal-use software costs. Personnel costs include those associated with support of the Company’s solution, customers and data center operations, as well as with providing professional services. Data center costs include costs for servers and equipment to build out and setup, as well as co-location fees for the right to place the Company’s servers in data centers owned by third parties.
Research and development expenses consist primarily of salary and related expenses, including stock-based compensation, for personnel related to the development of improvements and expanded features for the Company’s solution, as well as quality assurance, testing, product management and allocated overhead. Research and development costs are expensed as incurred except for internal use software development costs that qualify for capitalization. The Company reviews development costs incurred for internal-use software in the application development stage and assesses costs for capitalization.
Advertising Costs
The Company primarily advertises its services through the internet and in conjunction with partners. Advertising costs are expensed as incurred and were $25.4 million, $31.3 million and $28.1 million for the years ended December 31, 2024, 2023 and 2022, respectively.
Commissions
Commissions consist of variable compensation earned by sales personnel and referral fees the Company pays to third parties. The Company defers all incremental commission costs to obtain the contract, and amortizes these costs over a period of benefit determined to befive years. Commission expense was $77.0 million, $61.5 million and $47.3 million for the years ended December 31, 2024, 2023 and 2022, respectively.
All stock-based compensation granted to employees and non-employee directors is measured at the grant date fair value of the award. The Company estimates the fair value of stock options under the Company’s Equity Incentive Plans and purchase rights under the Company’s 2014 Employee Stock Purchase Plan (“2014 ESPP Plan” or “ESPP”) using the Black-Scholes option-pricing model. The fair value of restricted stock units (“RSUs”), including performance-based restricted stock units (“PRSUs”) subject to performance conditions, is equal to the fair value of the Company’s common stock on the date of grant. The fair value of PRSUs subject to market conditions are determined using a Monte Carlo Simulation model. Compensation expense is recognized net of actual forfeitures over the service period, which is generally the vesting period.
Income Taxes
The Company accounts for income taxes using the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in operations in the period that includes the enactment date. The Company records a valuation allowance to reduce its deferred tax assets to the amount of future tax benefit that is more likely than not to be realized. As of December 31, 2024 and 2023, the Company recorded a full valuation allowance against the U.S. net deferred tax assets because of its history of operating losses in the United States. As of December 31, 2024, the Company recognized a net deferred tax asset balance of $3.5 million related to its operations in Australia, Germany, India, Portugal and the U.K. As of December 31, 2023, the Company recognized a net deferred tax asset balance of $3.8 million related to its operations in Australia and Portugal, and placed a valuation allowance against its U.K. net deferred tax asset balance. The Company classifies interest and penalties on unrecognized tax benefits as income tax expense.
Comprehensive loss
Comprehensive loss consists of net loss, and unrealized gains or losses on available-for-sale marketable investments. The Company presents comprehensive loss as part of the consolidated statements of operations and comprehensive loss. The changes in the accumulated balances of the components of other comprehensive loss were not material for the periods presented.
Net Loss Per Share
Basic net loss per share is calculated by dividing net loss by the weighted average number of shares of common stock outstanding during the period, and excludes any dilutive effects of employee stock-based awards and potential shares issuable upon conversion of the convertible senior notes. Diluted net loss per share is computed giving effect to all potentially dilutive shares of common stock, including common stock issuable upon exercise of stock options, vesting of RSUs and PRSUs, and shares of common stock issuable upon conversion of convertible senior notes. In periods of net loss, all potentially issuable shares of common stock are excluded from the diluted net loss per share computation because they are anti-dilutive. Therefore, basic and diluted net loss per share are the same for all years presented in the Company’s consolidated statements of operations and comprehensive loss.
Indemnification
The Company, in the ordinary course of business, enters into agreements of varying scope and terms pursuant to which it agrees to indemnify customers, vendors, lessors, business partners and other parties with respect to certain matters, including, but not limited to, losses arising out of breach of such agreements, including breach of security, services to be provided by the Company or from intellectual property infringement claims made by third parties. To date, the Company has not incurred any material costs as a result of such indemnification provisions and the Company has not accrued any liabilities related to such obligations in the consolidated financial statements as of December 31, 2024 and 2023.
Recently Adopted Accounting Pronouncements
In November 2023, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standard Update (“ ASU”) No. 2023-07, Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures, which provides updates to qualitative and quantitative reportable segment disclosure requirements, including enhanced disclosures about significant segment expenses and increased interim disclosure requirements, among others. This ASU is effective for the Company’s fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted, and the amendments should be applied retrospectively. The Company’s adoption of ASU 2023-07 did not have a material impact on its financial position and results of operations but did result in incremental disclosures. See Note 11 for further information on the impact of this adoption.
Recent Accounting Pronouncements Not Yet Effective
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This ASU requires disclosure of specific categories in the effective tax rate reconciliation and additional information on income taxes paid. This ASU is effective for the Company’s fiscal years beginning after December 15, 2024. Early adoption is permitted and may be adopted on a prospective or retrospective basis. The Company is currently evaluating the impact of this ASU on its consolidated financial statement disclosures.
In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40). This ASU is intended to improve the decision-usefulness of expense information on public companies’ income statements through disaggregation of relevant expense captions in the notes to the financial statements. The ASU is effective for annual reporting periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027, with early adoption permitted. The Company is currently assessing the impact of this ASU on its consolidated financial statements and related disclosures.
In November 2024, the FASB issued ASU 2024-04, Debt with Conversion and Other Options (Subtopic 470-20), which clarifies the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. The ASU is effective for annual and interim reporting periods beginning after December 15, 2025. Early adoption is permitted for entities that have implemented ASU 2020-06, with the option to apply the guidance prospectively or retrospectively. The Company is currently assessing the impact of this ASU on its consolidated financial statements.
- Revenue
Contract Balances
The following table provides information about accounts receivable, net, deferred contract acquisition costs, net, contract assets and contract liabilities from contracts with customers (in thousands):
| December 31, 2024 | December 31, 2023 | |
|---|---|---|
| Accounts receivable, net | $115,172 | $97,424 |
| Deferred contract acquisition costs, net: | ||
| Current | $76,600 | $61,711 |
| Non-current | 155,157 | 136,571 |
| Total deferred contract acquisition costs, net | $231,757 | $198,282 |
| Contract assets and contract liabilities: | ||
| Contract assets (included in prepaid expenses and other current assets) | $7,206 | $4,106 |
| Contract liabilities (deferred revenue) | (79,173) | (68,187) |
| Noncurrent contract liabilities (deferred revenue) (included in other long term liabilities) | (865) | (1,350) |
| Net contract liabilities | $(72,832) | $(65,431) |
The Company receives payments from customers based upon billing cycles. Invoice payment terms are usually 30 days or less. Accounts receivable are recorded when the right to consideration becomes unconditional.
Deferred contract acquisition costs are recorded when incurred and are amortized over an estimated customer benefit period offive years.
The Company’s contract assets consist of unbilled amounts typically resulting from professional services where revenue is recognized in excess of total amounts billed to the customer. The Company’s contract liabilities consist of advance payments and billings in excess of revenue recognized.
In the year ended December 31, 2024, the Company recognized revenue of $55.8 million related to its contract liabilities at December 31, 2023.
Remaining Performance Obligations
As of December 31, 2024, the aggregate amount of the total transaction price allocated in contracts with original duration of greater than one year to the remaining performance obligations was $1,118.8 million. The Company expects to recognize revenue on approximately three-fourths of the remaining performance obligations over the next 24 months, with the balance recognized thereafter. The Company excludes amounts for remaining performance obligations that are part of contracts with an original expected duration of one year or less. Such remaining performance obligations represent unsatisfied or partially unsatisfied performance obligations.
- Investments and Fair Value Measurements
Marketable Investments
The Company’s marketable investments have been classified and accounted for as available-for-sale. The Company’s intent is that all marketable investments are available for use in its current operations, including marketable investments with maturity dates greater than one year from December 31, 2024. The Company’s marketable investments as of December 31, 2024 and 2023 were as follows (in thousands):
| Short-Term Marketable Investments | Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value |
|---|---|---|---|---|
| Certificates of deposit | $802 | $— | $— | $802 |
| U.S. treasury securities | 442,353 | 442 | (223) | 442,572 |
| U.S. agency and government-sponsored securities | 146,762 | 16 | (18) | 146,760 |
| Commercial paper | 9,600 | 8 | — | 9,608 |
| Corporate bonds | 43,550 | 124 | (6) | 43,668 |
| Total | $643,067 | $590 | $(247) | $643,410 |
| Short-Term Marketable Investments | Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value |
| Certificates of deposit | $1,463 | $— | $— | $1,463 |
| U.S. treasury securities | 315,608 | 191 | (362) | 315,437 |
| U.S. agency and government-sponsored securities | 239,358 | 78 | (177) | 239,259 |
| Commercial paper | 17,382 | 9 | — | 17,391 |
| Municipal bonds | 927 | 1 | — | 928 |
| Corporate bonds | 12,630 | 4 | (16) | 12,618 |
| Total | $587,368 | $283 | $(555) | $587,096 |
The following table presents the gross unrealized losses and the fair value for those marketable investments that were in an unrealized loss position for less than 12 months as of December 31, 2024 and 2023 (in thousands):
| December 31, 2024 · December 31, 2023 | ||||
|---|---|---|---|---|
| Less than 12 months | Less than 12 months | |||
| Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | Fair Value | |
| U.S. treasury securities | $(223) | $104,716 | $(362) | $79,644 |
| U.S. agency and government-sponsored securities | (18) | 76,484 | (177) | 165,493 |
| Corporate bonds | (6) | 4,219 | (16) | 7,550 |
| Total | $(247) | $185,419 | $(555) | $252,687 |
Although the Company had certain available-for-sale debt securities in an unrealized loss position as of December 31, 2024, no impairment loss was recorded since it did not intend to sell them, did not anticipate a need to sell them, and the decline in fair value was not due to any credit-related factors.
The amortized cost and fair value of the Company’s marketable investments by contractual maturity as of December 31, 2024 were as follows (in thousands):
| Cost | Fair Value | |
|---|---|---|
| Due within one year | $439,465 | $439,899 |
| Due after one year through two years | 203,602 | 203,511 |
| Total | $643,067 | $643,410 |
Fair Value Measurements
The Company carries cash equivalents and marketable investments at fair value. Fair value is based on the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:
Level 1 — Observable inputs, which include unadjusted quoted prices in active markets for identical assets or liabilities.
Level 2 — Observable inputs other than Level 1 inputs, such as quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 — Unobservable inputs that are supported by little or no market activity and that are based on management’s assumptions, including fair value measurements determined by using pricing models, discounted cash flow methodologies or similar techniques.
The Company determined the fair value of its Level 1 financial instruments, which are traded in active markets, using quoted market prices for identical instruments.
Marketable investments classified within Level 2 of the fair value hierarchy are valued based on other observable inputs, including broker or dealer quotations or alternative pricing sources. When quoted prices in active markets for identical assets or liabilities are not available, the Company relies on non-binding quotes from its investment managers, which are based on proprietary valuation models of independent pricing services. These models generally use inputs such as observable market data, quoted market prices for similar instruments, historical pricing trends of a security as relative to its peers. To validate the fair value determination provided by its investment managers, the Company reviews the pricing movement in the context of overall market trends and trading information from its investment managers. The Company performs routine procedures such as comparing prices obtained from independent sources to ensure that appropriate fair values are recorded.
The following tables set forth the Company’s assets measured at fair value by level within the fair value hierarchy (in thousands):
| Level 1 | Level 2 | Level 3 | Total | |
|---|---|---|---|---|
| Assets | ||||
| Cash equivalents | ||||
| Money market funds | $114,370 | $— | $— | $114,370 |
| Certificates of deposit | — | 496 | — | 496 |
| U.S. treasury securities | 42,946 | — | — | 42,946 |
| U.S. agency and government-sponsored securities | — | 41,832 | — | 41,832 |
| Commercial paper | — | — | — | — |
| Total cash equivalents | $157,316 | $42,328 | $— | $199,644 |
| Marketable investments | ||||
| Certificates of deposit | $— | $802 | $— | $802 |
| U.S. treasury securities | 442,572 | — | — | 442,572 |
| U.S. agency and government-sponsored securities | — | 146,760 | — | 146,760 |
| Commercial paper | — | 9,608 | — | 9,608 |
| Corporate bonds | — | 43,668 | — | 43,668 |
| Total marketable investments | $442,572 | $200,838 | $— | $643,410 |
| Level 1 | Level 2 | Level 3 | Total | |
| Assets | ||||
| Cash equivalents | ||||
| Money market funds | $66,661 | $— | $— | $66,661 |
| Certificates of deposit | — | 493 | — | 493 |
| U.S. treasury securities | 4,983 | — | — | 4,983 |
| Commercial paper | — | 1,498 | — | 1,498 |
| Total cash equivalents | $71,644 | $1,991 | $— | $73,635 |
| Marketable investments | ||||
| Certificates of deposit | $— | $1,463 | $— | $1,463 |
| U.S. treasury securities | 315,437 | — | — | 315,437 |
| U.S. agency and government-sponsored securities | — | 239,259 | — | 239,259 |
| Commercial paper | — | 17,391 | — | 17,391 |
| Municipal bonds | — | 928 | — | 928 |
| Corporate bonds | — | 12,618 | — | 12,618 |
| Total marketable investments | $315,437 | $271,659 | $— | $587,096 |
In March 2024, the Company issued $747.5 million aggregate principal amount of 1.00% convertible senior notes due 2029 (the "2029 convertible senior notes") in a private offering. In connection with the issuance of the 2029 convertible senior notes, the Company used part of the net proceeds from the issuance to repurchase approximately $313.1 million aggregate principal amount of its 0.50% convertible senior notes due 2025 (the "2025 convertible senior notes"). As of December 31, 2024 and December 31, 2023, the estimated fair value of the outstanding 2025 convertible senior notes was $423.2 million and $718.3 million, respectively. As of December 31, 2024, the estimated fair value of the outstanding 2029 convertible senior notes was $674.8 million. The fair values were determined based on the quoted price of the convertible senior notes in an inactive market on the last trading day of the reporting period and have been classified as Level 2 in the fair value hierarchy. See Note 6 for further information on the Company’s convertible senior notes.
In February 2022, the Company made a $2.0 million equity investment in a privately-held company that the Company does not have the ability to exercise significant influence over. The Company elected to utilize the measurement alternative for an equity security without a readily determinable fair value. Accordingly, this investment is accounted for at its cost minus impairment, if any, and is classified within Level 3. If the Company identifies observable price changes in orderly transactions for such investment or a similar investment, it will measure the investment at fair value as of the date that the observable transactions or events occurred. During 2024, the Company noted an indicator of impairment of this investment and recorded a $1.3 million impairment charge.
Except for the equity investment described above, there wereno assets or liabilities measured at fair value on a non-recurring basis as of December 31, 2024 and 2023.
The fair value of the Company’s other financial instruments, including accounts receivable, accounts payable and other current liabilities, approximate their carrying value due to the relatively short maturity of those instruments. The carrying amounts of the Company’s operating and finance leases approximate their fair value, which is the present value of expected future cash payments based on assumptions about current interest rates and the creditworthiness of the Company.
- Financial Statement Components
Cash and cash equivalents consisted of the following (in thousands):
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash | $162,902 | $69,566 |
| Money market funds | 114,370 | 66,661 |
| Certificates of deposit | 496 | 493 |
| U.S. treasury securities | 42,946 | 4,983 |
| U.S. agency and government-sponsored securities | 41,832 | — |
| Commercial paper | — | 1,498 |
| Total cash and cash equivalents | $362,546 | $143,201 |
Accounts receivable, net consisted of the following (in thousands):
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Trade accounts receivable | $99,551 | $86,912 |
| Unbilled trade accounts receivable, net of advance customer deposits | 15,962 | 10,776 |
| Provision for credit losses | (341) | (264) |
| Accounts receivable, net | $115,172 | $97,424 |
Prepaid expenses and other current assets consisted of the following (in thousands):
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Prepaid expenses | $27,988 | $22,023 |
| Other current assets | 15,646 | 8,493 |
| Contract assets | 7,206 | 4,106 |
| Prepaid expenses and other current assets | $50,840 | $34,622 |
Property and equipment, net consisted of the following (in thousands):
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Computer and network equipment | $173,671 | $155,997 |
| Computer software | 66,455 | 59,452 |
| Internal-use software development costs | 49,340 | 19,734 |
| Furniture and fixtures | 5,127 | 4,666 |
| Leasehold improvements | 6,736 | 6,425 |
| Property and equipment | 301,329 | 246,274 |
| Accumulated depreciation and amortization | (156,441) | (137,702) |
| Property and equipment, net | $144,888 | $108,572 |
Depreciation and amortization expense associated with property and equipment was $40.3 million, $36.5 million and $33.0 million for the years ended December 31, 2024, 2023 and 2022, respectively.
Other assets consisted of the following (in thousands):
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Other assets | $8,984 | $10,433 |
| Equity investment in a privately-held company | 750 | 2,000 |
| Deferred tax assets | 3,650 | 3,766 |
| Other assets | $13,384 | $16,199 |
Accrued and other current liabilities consisted of the following (in thousands):
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Accrued expenses | $30,822 | $18,282 |
| Accrued compensation and benefits | 44,002 | 35,927 |
| Accrued federal fees | 4,913 | 4,166 |
| Sales tax liabilities | 3,983 | 3,756 |
| Accrued and other current liabilities | $83,720 | $62,131 |
Other long-term liabilities consisted of the following (in thousands):
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Deferred revenue | $865 | $1,350 |
| Deferred tax liabilities | 186 | — |
| Sales tax liabilities | 244 | 926 |
| Other long-term liabilities | 5,422 | 5,612 |
| Other long-term liabilities | $6,717 | $7,888 |
- Goodwill and Intangible Assets
In 2024, goodwill of $138.2 million and intangible assets of $39.9 million were recorded as a result of the Company's acquisition of Acqueon, Inc. (“Acqueon”). In 2023, goodwill of $62.0 million and intangible assets of $22.1 million were recorded as a result of the Company’s acquisition of Aceyus, Inc. (“Aceyus”). See Note 14 for further details. The following table summarizes the activity in the Company's goodwill and intangible asset balances during the years ended December 31, 2024 and 2023 (in thousands):
| Goodwill | Intangible Assets | |
|---|---|---|
| Beginning of the period, January 1, 2023 | $165,420 | $28,192 |
| Addition (Aceyus) | 61,992 | 22,150 |
| Amortization | — | (12,019) |
| End of the period, December 31, 2023 | 227,412 | 38,323 |
| Addition (Acqueon) | 138,181 | 39,900 |
| Measurement period adjustment (Acqueon) | (14) | — |
| Measurement period adjustment (Aceyus) | (143) | — |
| Amortization | — | (12,591) |
| End of the period, December 31, 2024 | $365,436 | $65,632 |
During the fourth quarter of 2024, the Company completed its annual goodwill impairment test. Based on the Company’s assessment, it concluded that it is more likely than not that the fair values were more than their carrying values. Accordingly, there was no indication of impairment of goodwill, and further quantitative testing was not required. Subsequent to the 2024 annual impairment test, the Company believes there have been no significant events or circumstances negatively affecting the valuation of goodwill. As of December 31, 2024 and 2023, there wasno impairment to the carrying value of the Company’s goodwill.
The components of intangible assets were as follows (in thousands):
| December 31, 2024 · December 31, 2023 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Gross Carrying Amount | Accumulated Amortization | NetCarrying Amount | Weighted Average Remaining Amortization Period (Years) | GrossCarrying Amount | Accumulated Amortization | NetCarrying Amount | Weighted Average Remaining Amortization Period (Years) | |
| Developed technology | $105,714 | $(51,230) | $54,484 | 6.0 | $75,314 | $(40,327) | $34,987 | 5.2 |
| Acquired workforce | 470 | (470) | — | 0.0 | 470 | (470) | — | 0.0 |
| Customer relationships | 12,850 | (2,681) | 10,169 | 4.4 | 4,150 | (1,252) | 2,898 | 4.1 |
| Trademarks | 1,300 | (321) | 979 | 2.4 | 1,000 | (562) | 438 | 2.6 |
| Total | $120,334 | $(54,702) | $65,632 | 5.7 | $80,934 | $(42,611) | $38,323 | 5.1 |
Amortization expense related to intangible assets was $12.6 million, $12.0 million and $11.7 million for the years ended December 31, 2024, 2023 and 2022, respectively.
As of December 31, 2024, the expected future amortization expense for intangible assets was as follows (in thousands):
| Period | Expected Future Amortization Expense |
|---|---|
| 2025 | $14,467 |
| 2026 | 13,008 |
| 2027 | 8,612 |
| 2028 | 8,246 |
| 2029 | 7,328 |
| Thereafter | 13,971 |
| Total | $65,632 |
Intangible assets are reviewed for impairment whenever events or changes in circumstances indicate an asset’s carrying value may not be recoverable. The Company concluded that there wereno indicators of impairment of its intangible assets as of December 31, 2024 and 2023.
- Debt
Repurchase Transaction
In connection with the issuance of the 2029 convertible senior notes on March 1, 2024, the Company used part of the net proceeds from the issuance to repurchase approximately $313.1 million aggregate principal amount of the outstanding 2025 convertible senior notes in privately-negotiated transactions for aggregate cash consideration of approximately $304.9 million (the “Repurchase Transaction”).
The Repurchase Transaction was accounted for as a debt extinguishment. The difference between the consideration used to extinguish the 2025 convertible senior notes and the carrying value of the 2025 convertible senior notes (including unamortized debt discount and issuance costs) resulted in an extinguishment gain of approximately $6.6 million recorded in Other income (expense), net on the Company’s consolidated statements of operations and comprehensive loss.
In connection with the Repurchase Transaction, the Company also entered into a partial termination agreement with each bank counterparty and unwound a corresponding portion of the previously purchased capped call instruments entered into in connection with the issuance of the 2025 convertible senior notes (the “2025 Capped Calls”). The Company received approximately $0.5 million in cash in connection with these partial terminations, representing the fair value at the date of settlement of the unwound 2025 Capped Calls.
2029 Convertible Senior Notes and Related Capped Call Transactions
In March 2024, the Company issued $747.5 million aggregate principal amount of 2029 convertible senior notes in a private offering, which aggregate principal amount included the exercise in full of the initial purchasers’ option to purchase up to an additional $97.5 million principal amount of the 2029 convertible senior notes. The 2029 convertible senior notes mature on March 15, 2029 and bear interest at a fixed rate of 1.00% per annum, payable semiannually in arrears on March 15 and September 15 of each year, beginning on September 15, 2024. The total net proceeds from the issuance of the 2029 convertible senior notes, after deducting initial purchasers' discounts and commissions and estimated debt issuance costs, were approximately $728.8 million.
Each $1,000 principal amount of the 2029 convertible senior notes is initially convertible into 12.5918 shares of the Company’s common stock (the “2029 Conversion Option”), which is equivalent to an initial conversion price of approximately $79.42 per share of common stock, subject to adjustment upon the occurrence of specified events. The initial conversion price represents a premium of approximately 30% to the $61.09 per share closing price of the Company’s common stock on The Nasdaq Global Market on February 27, 2024. There have been no changes to the initial conversion price of the 2029 convertible senior notes since issuance. The 2029 convertible senior notes are convertible, in multiples of $1,000 principal amount, at the option of the holders prior to the close of business on the business day immediately preceding December 15, 2028, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on June 30, 2024 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during thefive business day period after anyfive consecutive trading day period (the “2029 Measurement Period”) in which the trading price (as defined in the 2029 Indenture governing the 2029 convertible senior notes) per $1,000 principal amount of the 2029 convertible senior notes for each trading day of the 2029 Measurement Period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate in effect on each such trading day; (3) if the Company calls any or all of the 2029 convertible senior notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or (4) upon the occurrence of specified corporate events. On or after December 15, 2028 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their 2029 convertible senior notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.
Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of the Company’s common stock or a combination of cash and shares of the Company’s common stock, at the Company’s election. If the Company undergoes a fundamental change (as defined in the indenture governing the 2029 convertible senior notes), subject to certain conditions, holders may require the Company to repurchase for cash all or any portion of their 2029 convertible senior notes, in principal amounts of $1,000 or a multiple thereof, at a fundamental change repurchase price equal to 100% of the principal amount of the 2029 convertible senior notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the fundamental change repurchase date. In addition, following certain corporate events or if the Company issues a notice of redemption, it will, under certain circumstances, increase the conversion rate for holders who elect to convert their notes in connection with such corporate event or during the relevant redemption period.
The closing market price of the Company's common stock of $40.64 per share on December 31, 2024, the last trading day during the three months ended December 31, 2024, was below $103.24 per share, which represents 130% of the initial conversion price of $79.42 per share. Additionally, the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day, December 31, 2024, was not greater than or equal to 130% of the initial conversion price. As such, during the three months ended December 31, 2024, the conditions allowing holders of the 2029 convertible senior notes to convert were not met. The 2029 convertible senior notes are therefore not convertible during the three months ending March 31, 2025.
The Company may not redeem the 2029 convertible senior notes prior to March 22, 2027. The Company may redeem for cash all or any portion of the 2029 convertible senior notes, at its option, on or after March 22, 2027 and prior to December 15, 2028, if the last reported sale price of its common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the 2029 convertible senior notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. However, the Company may not redeem less than all of the outstanding 2029 convertible senior notes unless at least $100.0 million aggregate principal amount of 2029 convertible senior notes are outstanding and not called for redemption at the time the redemption notice is sent. No sinking fund is provided for the 2029 convertible senior notes.
The 2029 convertible senior notes are the Company’s senior unsecured obligations and rank senior in right of payment to any of the Company’s indebtedness that is expressly subordinated in right of payment to the 2029 convertible senior notes; equal in right of payment to any of the Company’s unsecured indebtedness that is not so subordinated (including the 2025 convertible senior notes); effectively junior in right of payment to any of the Company’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities.
The net carrying amount of the 2029 convertible senior notes as of December 31, 2024 was as follows (in thousands):
| Principal | $747,500 |
|---|---|
| Unamortized issuance costs | (15,645) |
| Net carrying amount | $731,855 |
Interest expense related to the 2029 convertible senior notes was as follows (in thousands):
| Year Ended | |
|---|---|
| Contractual interest expense | $6,229 |
| Amortization of issuance costs | 3,013 |
| Total interest expense | $9,242 |
The debt issuance costs are amortized into interest expense over the term of the 2029 convertible senior notes at an effective interest rate of 1.49%.
In connection with the issuance of the 2029 convertible senior notes, the Company entered into privately negotiated capped call transactions (each a “2029 Capped Call,” and collectively the "2029 Capped Calls") with certain financial institutions. The 2029 Capped Call has an initial strike price of approximately $79.42, subject to certain adjustments, which corresponds to the initial conversion price of the 2029 convertible senior notes. The 2029 Capped Calls have an initial cap price of $122.18 per share, subject to certain adjustments. The 2029 Capped Calls are expected to partially offset the potential dilution to the Company’s common stock upon any conversion of the 2029 convertible senior notes, with such offset subject to a cap based on the cap price. Each 2029 Capped Call covers, subject to anti-dilution adjustments, approximately 9.4 million shares of the Company’s common stock. The 2029 Capped Call is subject to adjustment upon the occurrence of specified extraordinary events affecting the Company, including merger events, tender offers, and announcement events. In addition, each 2029 Capped Call is subject to certain specified additional disruption events that may give rise to a termination of the 2029 Capped Calls, including nationalization, insolvency or delisting, changes in law, failures to deliver, insolvency filings, and hedging disruptions. For accounting purposes, each 2029 Capped Call is treated as a separate transaction from, and not part of the terms of the 2029 convertible senior notes. As these transactions meet certain accounting criteria, the 2029 Capped Calls are recorded in stockholders' equity and are not accounted for as derivatives. The 2029 Capped Calls will not be remeasured as long as they continue to meet the conditions for equity classification.
2025 Convertible Senior Notes and Related Capped Call Transactions
In May and June 2020, the Company issued $747.5 million aggregate principal amount of 2025 convertible senior notes in a private offering, which aggregate principal amount included the exercise in full of the initial purchasers’ option to purchase up to an additional $97.5 million principal amount of the 2025 convertible senior notes. The 2025 convertible senior notes mature on June 1, 2025 and bear interest at a fixed rate of 0.500% per annum, payable semiannually in arrears on June 1 and December 1 of each year, beginning on December 1, 2020. The total net proceeds from the issuance of the 2025 convertible senior notes, after deducting initial purchasers' discounts and commissions and estimated debt issuance costs, were approximately $728.8 million.
In March 2024, the Company used part of the net proceeds from the issuance of the 2029 convertible senior notes to repurchase $313.1 million aggregate principal amount of the 2025 convertible senior notes in privately-negotiated transactions. As of December 31, 2024, after giving effect to the Repurchase Transaction, approximately $434.4 million aggregate principal amount of 2025 convertible senior notes remained outstanding.
Each $1,000 principal amount of the 2025 convertible senior notes is initially convertible into 7.4437 shares of the Company’s common stock (the “2025 Conversion Option”), which is equivalent to an initial conversion price of approximately $134.34 per share of common stock, subject to adjustment upon the occurrence of specified events. The initial conversion price represents a premium of approximately 30% to the $103.34 per share closing price of the Company’s common stock on The Nasdaq Global Market on May 21, 2020. There have been no changes to the initial conversion price of the 2025 convertible senior notes since issuance. The 2025 convertible senior notes are convertible, in multiples of $1,000 principal amount, at the option of the holders prior to the close of business on the business day immediately preceding March 1, 2025, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on September 30, 2020 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during thefive business day period after anyfive consecutive trading day period (the “2025 Measurement Period”) in which the trading price (as defined in the 2025 Indenture governing the 2025 convertible senior notes) per $1,000 principal amount of the 2025 convertible senior notes for each trading day of the 2025 Measurement Period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate in effect on each such trading day; (3) if the Company calls any or all of the 2025 convertible senior notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or (4) upon the occurrence of specified corporate events. On or after March 1, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their 2025 convertible senior notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.
Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of the Company’s common stock or a combination of cash and shares of the Company’s common stock, at the Company’s election. If the Company undergoes a fundamental change (as defined in the indenture governing the 2025 convertible senior notes), subject to certain conditions, holders may require the Company to repurchase for cash all or any portion of their 2025 convertible senior notes, in principal amounts of $1,000 or a multiple thereof, at a fundamental change repurchase price equal to 100% of the principal amount of the 2025 convertible senior notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the fundamental change repurchase date. In addition, following certain corporate events or if the Company issues a notice of redemption, it will, under certain circumstances, increase the conversion rate for holders who elect to convert their notes in connection with such corporate event or during the relevant redemption period.
The closing market price of the Company's common stock of $40.64 per share as of December 31, 2024, the last trading day during the three months ended December 31, 2024, was below $174.64 per share, which represents 130% of the initial conversion price of $134.34 per share. Additionally, the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day, December 31, 2024, was not greater than or equal to 130% of the initial conversion price. As such, during the three months ended December 31, 2024, the conditions allowing holders of the 2025 convertible senior notes to convert were not met. The 2025 convertible senior notes are therefore not convertible during the three months ending March 31, 2025 under this conditional conversion feature. However, on or after March 1, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their 2025 convertible senior notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.
The 2025 convertible senior notes became redeemable at the Company’s option on June 6, 2023. The Company may redeem for cash all or any portion of the 2025 convertible senior notes, at its option, prior to March 1, 2025, if the last reported sale price of its common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending not more thantwo trading days immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the 2025 convertible senior notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. No sinking fund is provided for the 2025 convertible senior notes. During the three months ended December 31, 2024, the conditions allowing the Company to redeem for cash all or any portion of the 2025 convertible senior notes were not met.
The 2025 convertible senior notes are the Company’s senior unsecured obligations and rank senior in right of payment to any of the Company’s indebtedness that is expressly subordinated in right of payment to the 2025 convertible senior notes; equal in right of payment to any of the Company’s unsecured indebtedness that is not so subordinated; effectively junior in right of payment to any of the Company’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities (including trade payables) of the Company’s subsidiaries.
The net carrying amount of the 2025 convertible senior notes as of December 31, 2024 and 2023 was as follows (in thousands):
| December 31, 2024 | December 31, 2023 | |
|---|---|---|
| Principal | $747,500 | $747,500 |
| Unamortized issuance costs | (915) | (5,375) |
| Principal repaid | (313,095) | — |
| Net carrying amount | $433,490 | $742,125 |
Interest expense related to the 2025 convertible senior notes was as follows (in thousands):
| Year Ended | |||
|---|---|---|---|
| December 31, 2024 | December 31, 2023 | December 31, 2022 | |
| Contractual interest expense | $2,433 | $3,737 | $3,737 |
| Amortization of issuance costs | 2,465 | 3,749 | 3,711 |
| Total interest expense | $4,898 | $7,486 | $7,448 |
The debt issuance costs are amortized into interest expense over the term of the 2025 convertible senior notes at an effective interest rate of 1.00%.
In connection with the issuance of the 2025 convertible senior notes, the Company entered into privately negotiated capped call transactions (each a “2025 Capped Call,” and collectively the "2025 Capped Calls") with certain financial institutions. The 2025 Capped Calls each have an initial strike price of approximately $134.34, which corresponds to the initial conversion price of the 2025 convertible senior notes. The initial cap price of the 2025 Capped Calls was $206.68 per share and is subject to certain adjustments under the terms of the 2025 Capped Calls. In connection with the Repurchase Transaction, the Company unwound a portion of the 2025 Capped Calls. Refer to the Repurchase Transaction section above for further information. There are no changes or amendments made to the remaining 2025 Capped Calls. The remaining 2025 Capped Calls cover, subject to anti-dilution adjustments, approximately 3.2 million shares of the Company’s common stock. Each 2025 Capped Call is subject to adjustment upon the occurrence of specified extraordinary events affecting the Company, including merger events, tender offers, and announcement events. In addition, each 2025 Capped Call is subject to certain specified additional disruption events that may give rise to a termination of each 2025 Capped Call, including nationalization, insolvency or delisting, changes in law, failures to deliver, insolvency filings, and hedging disruptions. For accounting purposes, each 2025 Capped Call is a separate transaction from, and not part of the terms of the 2025 convertible senior notes. As these transactions meet certain accounting criteria, the 2025 Capped Calls are recorded in stockholders' equity and are not accounted for as derivatives. The 2025 Capped Calls will not be remeasured as long as they continue to meet the conditions for equity classification.
- Stockholders’ Equity
Capital Structure
Common Stock
The Company is authorized to issue 450,000,000 shares of common stock with a par value of $0.001 per share. As of December 31, 2024 and 2023, the Company had 75,807,505 and 73,316,968 shares of common stock issued and outstanding, respectively.
During 2023, the Company issued 1,445 shares of common stock in connection with 2023 convertible senior note settlements. During 2023, the Company also received 370,877 shares from the partial unwind and settlement of capped calls resulting from the settlement of its 2023 convertible senior notes. The receipt of the 370,877 shares reduced the number of shares of common stock outstanding.
Holders of the Company’s common stock are entitled to dividends, if and when declared by the board of directors. In the event of liquidation, dissolution or winding up, subject to the rights of the holders of any then outstanding shares of preferred stock, holders of common stock will be entitled to receive the assets and funds of the Company that are legally available for distribution.
Preferred Stock
The Company is authorized to designate and issue up to 5,000,000 shares of preferred stock with a par value of $0.001 per share in one or more series without stockholder approval and to fix the rights, preferences, privileges and restrictions thereof. As of December 31, 2024 and 2023, there wereno shares of preferred stock issued and outstanding.
Common Stock Reserved for Future Issuance
Shares of common stock reserved for future issuance related to outstanding equity awards and employee equity incentive plans as of December 31, 2024, were as follows (in thousands):
| Common Stock Reserved | |
|---|---|
| Stock options outstanding | 860 |
| RSUs (including PRSUs) outstanding | 5,829 |
| Shares available for future grant under 2014 Plan | 15,506 |
| Shares available for future issuance under ESPP | 4,298 |
| Total shares of common stock reserved | 26,493 |
Equity Incentive Plans
Prior to the Company’s initial public offering (“IPO”) in April 2014, the Company granted stock options under its Amended and Restated 2004 Equity Incentive Plan, as amended (“2004 Plan”).
Under the terms of the 2004 Plan, the Company had the ability to grant incentive and nonstatutory stock options. Incentive stock options could only be granted to Company employees. Nonstatutory stock options could be granted to Company employees, directors and consultants. Such options are exercisable at prices, as determined by the board of directors, generally equal to the fair value of the Company’s common stock at the date of grant. Options granted to employees generally vest over afour-year period, with an initial vesting period of 12 months for 25% of the shares, and the remaining 75% of the shares vesting monthly on a ratable basis over the remaining 36 months. Options generally expire 10 years after the grant date and are generally exercisable upon vesting. Vested options generally expire 90 days after termination of the optionee’s employment or relationship as a consultant or director, unless otherwise extended by the terms of the stock option agreement.
In March 2014, the Company’s board of directors and stockholders approved the 2014 Equity Incentive Plan (“2014 Plan”) and 5,300,000 shares of common stock were authorized for issuance under the 2014 Plan. In addition, on the first day of each year beginning in 2015 and ending in 2024, the 2014 Plan provides for an annual automatic increase to the shares reserved for issuance in an amount equal to 5% of the total number of shares outstanding on December 31st of the preceding calendar year or a lesser number as determined by the Company’s board of directors. No further grants were made under the 2004 Plan once the 2014 Plan became effective on April 3, 2014. Upon the effectiveness of the 2014 Plan, all shares reserved for future issuance under the 2004 Plan became available for issuance under the 2014 Plan. Additionally, any forfeited or expired shares that would have otherwise returned to the 2004 Plan, instead return to the 2014 Plan. The 2014 Plan allows the Company to grant stock options, RSUs, restricted stock awards, performance stock awards, stock appreciation rights, performance cash awards, and other stock awards. To date, the Company has granted stock options and RSUs (including PRSUs) under the 2014 Plan. Stock options granted under the 2014 Plan are in general at a price equal to the fair market value of the common stock on the date of grant and vest over four years. The Company’s stock options expire 10 years from the date of grant. Each RSU granted under the 2014 Plan represents a right to receiveone share of the Company’s common stock when the RSU vests. RSUs generally vest overone tofour years. Vested options generally expire three months after termination of the optionee’s employment or relationship as a consultant or director, unless otherwise extended by the terms of the stock option agreement.
In connection with the Company’s acquisition of Inference in 2020, the Company assumed unvested stock options that had been granted under the Inference Technologies Group Inc. 2018 Equity Incentive Plan. Each of the assumed stock options are subject to substantially the same terms and conditions as applied to the assumed stock options immediately prior to the acquisition date, except that the number of shares of the Company’s common stock subject to each assumed stock option and the exercise price has been adjusted in accordance with the terms of the acquisition agreement. If these assumed stock options are cancelled, forfeited or expire unexercised, the underlying shares do not become available for future grant. As of the acquisition date, the estimated fair value of the assumed unvested options was $7.6 million, of which $0.2 million was recognized as goodwill and the balance of $7.4 million is being recognized as stock-based compensation expense over the remaining service period of the assumed unvested stock options.
Stock Options
A summary of the Company’s stock option activity during the year ended December 31, 2024 is as follows (in thousands, except years and per share data):
| Number of Shares | Weighted Average Exercise Price | WeightedAverageRemainingContractualLife(Years) | Aggregate Intrinsic Value (1) | |
|---|---|---|---|---|
| Outstanding as of December 31, 2023 | 918 | $55.96 | ||
| Options granted | 0 | 0.00 | ||
| Options exercised | (26) | 18.93 | ||
| Options forfeited or expired | (32) | 100.86 | ||
| Outstanding as of December 31, 2024 | 860 | 55.34 | 3.7 | $10,348 |
| Vested and expected to vest as of December 31, 2024 | 860 | 55.34 | 3.7 | 10,348 |
| Exercisable as of December 31, 2024 | 837 | 53.35 | 3.6 | 10,348 |
(1) The aggregate intrinsic value amounts are computed based on the difference between the exercise price of the
stock options and the fair market value of the Company’s common stock of $40.64 per share as of December 31, 2024 for all in-the-money stock options outstanding.
Following is additional information pertaining to the Company’s stock option activity (in thousands, except per share data):
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Weighted average grant date fair value per share of options granted | $— | $— | $50.44 |
| Intrinsic value of options exercised (1) | 901 | 26,943 | 45,698 |
| Total fair value of options vested during the period | 3,249 | 5,602 | 11,421 |
| Cash received from options exercised | 481 | 9,127 | 8,522 |
| (1) Intrinsic value of options exercised is the difference between the fair market value of the Company’s common stock at the time of exercise and the exercise price paid. | |||
Restricted Stock Units (including PRSUs)
A summary of RSU activity (including PRSUs) during the year ended December 31, 2024 is as follows (in thousands, except per share data):
| Number of Shares | Weighted Average Grant Date Fair Value Per Share | |
|---|---|---|
| Outstanding as of December 31, 2023 | 4,076 | $83.25 |
| RSUs granted(1) | 4,433 | 46.32 |
| RSUs vested and released | (2,093) | 79.87 |
| RSUs forfeited or cancelled | (587) | 71.10 |
| Outstanding as of December 31, 2024 | 5,829 | 57.27 |
(1) Includes 159,016 PRSUs granted during 2024.
PRSUs with Market and Service Conditions. In 2022, the Company granted 284,282 PRSUs subject to market and service conditions (“market-based PRSUs”) with a grant date fair value of $30.6 million as part of its annual grant of equity incentive awards to certain executives and in connection with the appointment of Michael Burkland as its new Chief Executive Officer. In 2023, the Company granted 35,921 market-based PRSUs with a grant date fair value of $3.1 million. In 2024, the Company granted an additional 159,016 market-based PRSUs with a grant date fair value of $9.6 million. The amount that may be earned pursuant to the market-based PRSUs ranges from 0% to 200% of the target number based on the Company’s relative total shareholder return (“RTSR”) performance as compared to the companies in the S&P Software and Services Select Index during three one-year performance periods. One-third of the total market-based PRSUs may be earned and settled in shares following the end of each -year performance period based on RTSR performance and subject to continued employment through the payment date. If the Company’s absolute total shareholder return for any performance period is negative, then no more than 100% of the target amount of market-based PRSUs for such period may be earned. If an executive's employment with the Company terminates before the end of the finalone-year performance period due to death or disability,100% (if due to death) or 50% (if due to disability) of the unvested market-based PRSUs may be earned subject to ultimate RTSR performance in each remaining performance period. Upon a qualifying termination of employment in connection with a change in control of the Company, the unvested market-based PRSUs will vest on a double-trigger basis (i) at the target level for the market-based PRSUs subject to the 2022-2024 performance period, (ii) for the market-based PRSUs subject to the 2023-2025 performance period, and (iii) for the market-based PRSUs subject to the 2024-2026 performance period, (a) at the target level for the uncompleted portions of the performance periods and (b) at the actual level of performance measured through the date of the change in control of the Company, based on the price per share paid in such change in control. The fair value of the market-based PRSUs is determined on their grant date using a Monte Carlo Simulation model based upon assumptions presented below. The Company recognizes the fair value of the market-based PRSUs ratably over their requisite service period.
During the first quarter of 2023, the Company certified the performance results for the 2022 measurement period for the market-based PRSUs subject to the 2022-2024 performance period. Under the market-based PRSU agreements, the TSR payout percentage ranges from 0% to 200%, with a 50% payout at the 25th TSR percentile (threshold),100% payout at the 55th TSR percentile (target),200% payout at the 90th percentile or greater (maximum) and no payout below the threshold performance level. The Company determined that its actual total shareholder return was -52.64% for 2022, and that its relative total shareholder return ranking was in the 30.2 percentile relative to companies in the S&P Software & Services Select Index, which resulted in a payout percentage of 58.7% of target. During the first quarter of 2024, the Company certified the performance results for the 2023 measurement period for the market-based PRSUs subject to the 2022-2024 performance period. The Company determined that its actual total shareholder return was 19.95% for 2023, and that its relative total shareholder return ranking was in the 53.8 percentile relative to companies in the S&P Software & Services Select Index, which resulted in a payout percentage of 98.0% of target. During the first quarter of 2024, the Company also certified the performance results for the 2023 measurement period for the market-based PRSUs subject to the 2023-2025 performance period. The Company determined that its actual total shareholder return was 19.95% for 2023, and that its relative total shareholder return ranking was in the 50.5 percentile relative to companies in the S&P Software & Services Select Index, which resulted in a payout percentage of 92.5% of target. During the first quarter of 2025, the Company certified the performance results for the 2024 measurement period for the market-based PRSUs subject to the 2022-2024 performance period. The Company determined that its actual total shareholder return was (47.25)% for 2024, and that its relative total shareholder return ranking was in the 3.7 percentile relative to companies in the S&P Software & Services Select Index, which resulted in a payout percentage of 0.00% of target. During the first quarter of 2025, the Company certified the performance results for the 2024 measurement period for the market-based PRSUs subject to the 2023-2025 performance period. The Company determined that its actual total shareholder return was (47.25)% for 2024, and that its relative total shareholder return ranking was in the 2.9 percentile relative to companies in the S&P Software & Services Select Index, which resulted in a payout percentage of 0.0% of target. During the first quarter of 2025, the Company also certified the performance results for the 2024 measurement period for the market-based PRSUs subject to the 2024-2026 performance period. The Company determined that its actual total shareholder return was (47.25)% for 2024, and that its relative total shareholder return ranking was in the 1.5 percentile relative to companies in the S&P Software & Services Select Index, which resulted in a payout percentage of 0.0% of target.
PRSUs with Revenue and Service Conditions. In 2022, the Company granted 66,167 PRSUs subject to revenue-based performance and service conditions (“revenue-based PRSUs”) with a grant date fair value of $6.6 million. The amount of revenue-based PRSUs that may be earned will be determined based on achievement oftwo quarterly revenue goals. One third of the revenue-based PRSUs may be earned based on achievement of the first revenue target and, if achieved, will vest infour quarterly installments, with the first installment occurring on the date such achievement is certified, subject to the executive's continuous service through the applicable vesting dates. Two thirds of the revenue-based PRSUs may be earned based on achievement of the second revenue target and, if achieved, will vest ineight quarterly installments, with the first installment occurring on the date such achievement is certified, subject to the executive's continuous service through the applicable vesting dates. The revenue-based PRSUs are otherwise on the Company's standard award terms for its market-based PRSUs. During 2023, the Company certified that the first revenue target was achieved, and thus recognized the related stock-based compensation expense for this first revenue target. However, the Company certified during the first quarter of 2024 that, as of December 31, 2023, the second revenue target was not achieved, and thus did not recognize the related stock-based compensation expense and cancelled the shares associated with this target.
Following is additional information pertaining to the Company’s RSU activity (including PRSUs) (in thousands, except per share data):
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Weighted average grant date fair value per share of RSUs granted | $46.32 | $69.84 | $90.51 |
| Total fair value of RSUs vested during the period | 167,115 | 184,443 | 125,798 |
Employee Stock Purchase Plan
In March 2014, the Company’s board of directors and stockholders adopted the 2014 ESPP and the shares authorized for issuance thereunder. The 2014 ESPP became effective on April 3, 2014.
The 2014 ESPP permits eligible employees to purchase shares of the Company’s common stock through payroll deductions with up to 15% of their pre-tax earnings subject to certain Internal Revenue Code limitations. The purchase price of the shares is 85% of the lower of the fair market value of the Company’s common stock on the first day of asix month offering period, except for the initial offering period, or the relevant purchase date. In addition, no participant may purchase more than 1,500 shares of common stock in each purchase period.
The number of shares of common stock originally reserved for issuance under the 2014 ESPP was 880,000 shares, which increases automatically each year, beginning on January 1, 2015 and continuing through January 1, 2024, by the lesser of (i)1% of the total number of shares of the Company’s common stock outstanding on December 31 of the preceding calendar year; (ii)1,000,000 shares of common stock (subject to adjustment to reflect any split or combination of its common stock); or (iii) such lesser number as determined by its board of directors.
During 2024 and 2023,372,046 and 344,309 shares were purchased by employees under the 2014 ESPP at a weighted average price of $39.77 and $46.26 per share, respectively.
Stock-based compensation expenses for the years ended December 31, 2024, 2023 and 2022 were as follows (in thousands):
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Cost of revenue | $29,825 | $38,259 | $33,297 |
| Research and development | 37,260 | 50,430 | 44,367 |
| Sales and marketing | 51,214 | 66,229 | 59,300 |
| General and administrative | 48,016 | 51,374 | 35,543 |
| Total stock-based compensation | $166,315 | $206,292 | $172,507 |
As of December 31, 2024, unrecognized stock-based compensation expense by award type and their expected weighted-average recognition periods are summarized in the following table (in thousands, except years).
| Stock Option | RSU (excluding PRSUs) | PRSU | ESPP | |
|---|---|---|---|---|
| Unrecognized stock-based compensation expense | $1,246 | $294,832 | $10,376 | $2,714 |
| Weighted-average amortization period | 0.9 years | 2.8 years | 1.4 years | 0.4 years |
The Company recognizes stock-based compensation expense that is calculated based upon awards that have vested, reduced for actual forfeitures. All stock-based compensation for equity awards granted to employees and non-employee directors is measured based on the grant date fair value of the award.
The Company values RSUs, including PRSUs subject to performance conditions, at the closing market price of its common stock on the date of grant. The Company estimates the fair value of each stock option and purchase right under the 2014 ESPP granted to employees on the date of grant using the Black-Scholes option-pricing model using the assumptions disclosed in the table below. The Company estimates the fair value of PRSUs subject to market conditions using a Monte Carlo Simulation model using the assumptions disclosed in the table below. Expected volatility is based upon the weighting of the Company’s historical volatility. The expected term of options granted is estimated using the simplified method by taking the average of the vesting term and the contractual term of the option. The expected volatility assumption for purchase rights under the 2014 ESPP is based on the historical volatility of the Company’s common stock. The risk-free rate for the expected term of the awards is based on U.S. Treasury zero-coupon issues at the time of grant. The Company has not paid, and does not anticipate paying, cash dividends on its shares of common stock. Accordingly, the expected dividend yield iszero.
The weighted average assumptions used to value stock options granted during the periods presented were as follows:
| Stock Options | Year Ended December 31, | ||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Expected term (years) | — | — | 6.0 |
| Volatility | — | — | 46% |
| Risk-free interest rate | — | — | 1.8% |
| Dividend yield | — | — | — |
The weighted average assumptions used to value PRSUs with market conditions granted during the periods presented were as follows:
| PRSUs (Market Conditions) | Year Ended December 31, | ||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Expected term (years) | 2.9 | 2.8 | 3.0 |
| Volatility | 49.4% | 51.1% | 53.0% |
| Risk-free interest rate | 4.5% | 4.5% | 3.5% |
| Dividend yield | — | — | — |
The weighted average assumptions used to value purchase rights under the 2014 ESPP granted during the periods presented were as follows:
| ESPP | Granted In | |||||
|---|---|---|---|---|---|---|
| November 2024 | May 2024 | November 2023 | May 2023 | November 2022 | May 2022 | |
| Expected term (years) | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| Volatility | 63% | 41% | 48% | 75% | 59% | 46% |
| Risk-free interest rate | 4.3% | 5.1% | 4.8% | 4.6% | 2.1% | 0.2% |
| Dividend yield | — | — | — | — | — | — |
- Net Loss Per Share
Basic net loss per share is calculated by dividing net loss by the weighted average number of shares of common stock outstanding during the period, and excludes any dilutive effects of employee stock-based awards and potential shares upon conversion of the convertible senior notes. Diluted net loss per share is computed giving effect to all potentially dilutive shares of common stock, including common stock issuable upon exercise of stock options, vesting of RSUs and PRSUs, and shares of common stock issuable upon conversion of convertible senior notes. As the Company had net losses for the years ended December 31, 2024, 2023 and 2022, all potentially issuable shares of common stock were determined to be anti-dilutive.
The following table presents the calculation of basic and diluted net loss per share (in thousands, except per share data):
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Net loss | $(12,795) | $(81,764) | $(94,650) |
| Weighted-average shares used in computing basic and diluted net loss per share | 74,503 | 72,048 | 69,920 |
| Basic and diluted net loss per share | $(0.17) | $(1.13) | $(1.35) |
The following securities were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive (in thousands):
| December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Stock options | 860 | 918 | 1,481 |
| RSUs (including PRSUs) | 5,829 | 4,076 | 3,718 |
| Convertible senior notes | 11,466 | 5,566 | 5,685 |
| Total | 18,155 | 10,560 | 10,884 |
The Company used the if-converted method for calculating any potential dilutive effect of its convertible senior notes for the years ended December 31, 2024, 2023 and 2022. Under this method, the Company calculates diluted earnings per share under both the cash and share settlement assumptions to determine which is more dilutive. If share settlement is more dilutive, the Company calculates diluted earnings per share assuming that all of the convertible senior notes were converted solely into shares of common stock at the beginning of the reporting period. The potential impact upon the conversion of the convertible senior notes were excluded from the calculation of diluted net loss per share for the years ended December 31, 2024, 2023 and 2022 because the effect would have been anti-dilutive.
- Income Taxes
The following table presents components of loss before income taxes for the periods presented (in thousands):
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| United States | $(22,903) | $(80,348) | $(76,280) |
| International | 10,148 | 925 | (13,982) |
| Loss before income taxes | $(12,755) | $(79,423) | $(90,262) |
Provision for (benefit from) income taxes for the periods presented consisted of (in thousands):
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Current: | |||
| U.S. federal | $519 | $— | $— |
| U.S. state | 2,728 | 2,531 | 576 |
| Foreign | 1,628 | (243) | 724 |
| Total provision for income taxes - Current | 4,875 | 2,288 | 1,300 |
| Deferred: | |||
| U.S. federal | (4,308) | — | — |
| U.S. state | (1,174) | — | — |
| Foreign | 647 | 53 | 3,088 |
| Total (benefit from) provision for income taxes - Deferred | (4,835) | 53 | 3,088 |
| Total provision for income taxes | $40 | $2,341 | $4,388 |
The Company recorded current income tax expense during 2024 principally due to U.S. taxable income as a result of IRC Section 174 research and experimental capitalization requirements. The Company offset federal taxable income through the utilization of available net operating loss carryforward attributes. However, the Company was subject to net operating loss utilization limitations in some U.S. federal and state jurisdictions. These considerations were partially offset by the Company's acquisition of Acqueon, which carried a U.S. net deferred tax liability balance and provided the Company with a source of taxable income to release a portion of the consolidated U.S. valuation allowance.
Income tax expense differed from the amount computed by applying the U.S. federal statutory income tax rate of 21% to pre-tax (loss) income for the periods presented as a result of the following (in thousands):
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| U.S. federal tax at statutory rate | $(2,679) | $(16,676) | $(18,957) |
| U.S. state income taxes | 1,553 | 2,531 | 576 |
| Section 162(m) | 4,474 | 6,417 | 3,851 |
| Global intangible low-taxed income | — | (4,002) | 4,127 |
| Effect of waived tax deductions - Base Erosion and Anti-Abuse Tax | (7,751) | 7,751 | — |
| Miscellaneous permanent tax adjustments | 26 | 230 | 78 |
| Research and development credit | (1,383) | (943) | (1,194) |
| Stock-based compensation | 16,981 | 10,829 | 1,722 |
| Transaction costs | 862 | 415 | — |
| Tax benefit from acquisition/reorganizations | (4,308) | — | (3,852) |
| Foreign tax rate differential | 525 | (383) | 6,749 |
| Adjustments related to tax positions taken during prior years | (2,083) | 249 | — |
| Change in valuation allowance | (6,177) | (4,077) | 11,288 |
| Total provision for income taxes | $40 | $2,341 | $4,388 |
The tax effects of temporary differences that give rise to significant portions of the Company’s deferred tax assets and liabilities as of December 31, 2024 and 2023 related to the following (in thousands):
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Deferred tax assets: | ||
| Net operating loss and credit carryforwards | $91,826 | $115,137 |
| Capitalized R&D costs | 78,961 | 55,167 |
| Accrued liabilities | 872 | 617 |
| Provision for credit losses | 671 | 1,236 |
| Property and equipment | 35 | — |
| Amortizable intangibles | — | 29 |
| Deferred revenue | 3,687 | 2,440 |
| Accrued compensation | 5,797 | 4,132 |
| Long-term lease liabilities | 15,928 | 11,171 |
| Stock-based compensation | 10,224 | 9,190 |
| Deferred interest expense | 349 | — |
| Other | 755 | — |
| Gross deferred tax assets | 209,105 | 199,119 |
| Valuation allowance | (123,141) | (134,802) |
| Net deferred tax assets | 85,964 | 64,317 |
| Deferred tax liabilities: | ||
| Property and equipment | (8,647) | (7,037) |
| Amortizable intangibles | (7,697) | — |
| Right of use assets | (13,493) | (9,092) |
| Deferred contract acquisition costs | (52,663) | (44,217) |
| Other | — | (205) |
| Gross deferred tax liabilities | (82,500) | (60,551) |
| Net deferred taxes | $3,464 | $3,766 |
To enhance clarity, the Company has revised certain disclosures in its effective tax rate reconciliation and disclosure of its deferred tax assets and liabilities, and has conformed prior year disclosures to ensure comparability with the current year.
With the exception of Russia, the Company has not provided for U.S. income taxes on undistributed earnings of its foreign subsidiaries because it intends to permanently re-invest those earnings outside the United States. The Company has plans to liquidate its Russian subsidiary. As such, the Company no longer asserts an intention to permanently re-invest those earnings. The undistributed earnings of the Company’s foreign subsidiaries were immaterial as of December 31, 2024 and 2023 and no U.S. income taxes have been accrued.
A valuation allowance is provided for deferred tax assets where the recoverability of the assets is uncertain. The determination to provide a valuation allowance is dependent upon the assessment of whether it is more likely than not that sufficient future taxable income will be generated to utilize the deferred tax assets. Based on the weight of the available evidence, which includes the Company’s historical operating losses, lack of taxable income and the accumulated deficit for the year ended December 31, 2024, the Company has provided a valuation allowance against its U.S. net deferred tax assets. The Company has recorded net foreign deferred tax assets associated with its Australia, Germany, India, Portugal and the U.K. operations totaling $3.5 million since management has assessed it is more likely than not that the results of future operations within these jurisdictions will generate sufficient taxable income to realize the deferred tax assets. The foreign deferred tax assets cannot increase its U.S. valuation allowance. The net change in the valuation allowance for the years ended December 31, 2024 and 2023 were decreases of $11.7 million and $0.6 million, respectively. The decrease of the valuation allowance in the current year was primarily attributed to the Company’s acquisition of Acqueon, which provided a source of future U.S. taxable income to support a reduction in the consolidated U.S. valuation allowance.
As of December 31, 2024, the Company had net operating loss carryforwards for federal, state and foreign income tax purposes of $310.1 million, $254.3 million and $7.3 million, respectively, available to reduce future income subject to income taxes. If not utilized, various amounts of significant state net operating loss carryforwards will begin to expire in 2028, while $310.1 million of federal net operating losses, as well as the foreign net operating losses, do not expire. As of December 31, 2024, the Company also had gross research credit carryforwards for federal and California state tax purposes of $14.1 million and $8.6 million, available to reduce future income subject to income taxes. The federal research credit carryforwards will expire between 2025 and 2044. The California state research credits do not expire. The IRC imposes restrictions on the utilization of net operating losses and credits in the event of an “ownership change” of a corporation. Accordingly, a company’s ability to use net operating losses and credits may be subject to substantial limitation as prescribed under the IRC Sections 382 and 383 and similar state provisions. Events that may cause limitations in the amount of the net operating losses and credits that the Company may use in any one year include, but are not limited to, a cumulative ownership change of more than 50% over athree-year period. In the event the Company has changes in ownership, net operating losses and research and development credit carryforwards, which are fully reserved by the deferred tax asset valuation allowance, could be limited and may expire unutilized.
Unrecognized Tax Benefits
The table below shows the changes in the gross amount of unrecognized tax benefits for the periods presented (in thousands):
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Unrecognized benefit — beginning of period | $11,124 | $9,415 | $7,643 |
| Gross increases — current year tax positions | 2,502 | 1,413 | 1,773 |
| Gross increases — prior year tax positions | 40 | 299 | — |
| Gross decreases — prior year tax positions | (91) | (3) | (1) |
| Settlements with tax authorities | — | — | — |
| Unrecognized benefit — end of period | $13,575 | $11,124 | $9,415 |
As of each of December 31, 2024 and 2023, the Company had unrecognized tax benefits that, if recognized, would impact its effective tax rate by $1.0 million and $0.5 million, respectively. The Company recognizes interest and penalties related to uncertain tax positions as income tax expense, which has cumulatively been immaterial to the financial statements. The Company does not anticipate its total unrecognized tax benefits as of December 31, 2024 will significantly change due to settlement of examination or the expiration of statutes of limitation during the next 12 months. The Company is currently unaware of any uncertain tax positions that could result in significant additional payments, accruals or other material deviation in this estimate over the next 12 months.
The Company is subject to taxation in the United States, various states and several foreign jurisdictions. Due to the Company’s recently utilized and net carryover of unused operating losses, all years from 2004 forward remain subject to future examination by the U.S. federal and state tax authorities. The Company’s foreign tax returns are open to audit under the statutes of limitation of the respective foreign countries in which the subsidiaries are located. With the exception of Russia, the Company considers all undistributed earnings of its foreign subsidiaries indefinitely reinvested.
- Commitments and Contingencies
Commitments
As of December 31, 2024, (i) $434.4 million of aggregate principal of the 2025 convertible senior notes was outstanding and is due on June 1, 2025, and (ii) $747.5 million of aggregate principal of the 2029 convertible senior notes was outstanding and is due on March 15, 2029. See Note 6 for more information concerning the convertible senior notes.
The Company had outstanding operating lease and finance lease obligations of $53.3 million and $20.8 million, respectively, as of December 31, 2024. See Note 13 for further details. As of December 31, 2024, the Company also had outstanding cloud services and software and maintenance agreement commitments totaling $38.1 million, of which $20.0 million is expected to be purchased in 2025 and $18.1 million is expected to be purchased in 2026. During 2024, the Company entered into equipment finance lease arrangements that resulted in a $8.8 million additional reduction of its outstanding cloud services commitment.
Hosting and Telecommunication Usage Services
The Company has agreements with third parties to provide co-location hosting and telecommunication usage services. The agreements require payments per month for a fixed period of time in exchange for certain guarantees of network and telecommunication availability.
As of December 31, 2024, future minimum payments under these arrangements were as follows (in thousands):
| Year Ending December 31, | Hosting Services | Telecommunication Usage Services |
|---|---|---|
| 2025 | $4 | $6,712 |
| 2026 | — | 4,870 |
| 2027 | — | 1,768 |
| 2028 | — | 1,050 |
| 2029 | — | 233 |
| Thereafter | — | — |
| Total future minimum payment | $4 | $14,633 |
Universal Services Fund Liability
The Company is classified as a telecommunications service provider for regulatory purposes and is required to make contributions to the USF based on the revenue the Company receives from the resale of interstate and some international telecommunications services. In order to comply with the obligation to make direct contributions, the Company is registered with the USAC, which is charged by the FCC with administering the USF, and has been remitting the required contributions to USAC since its registration with the USAC in April 2013. The Company also made retroactive USF contributions based on its revenues for the period from 2008 to 2012. The Company, however, has an unresolved and arguably dormant dispute with the FCC regarding whether the Company is liable for USF contributions related to the period from 2003 through 2007. As of December 31, 2024, the Company had accrued $0.1 million in interest related to the disputed assessments for the period of 2003 through 2007.
State and Local Taxes and Surcharges
The Company, based on analysis of its activities, has determined that it is obligated to collect and remit U.S. state or local sales, use, gross receipts, excise and utility user taxes, as well as fees or surcharges as a communications service provider in certain U.S. states, municipalities or local tax jurisdictions. The Company is registered for, collecting and remitting applicable taxes where such a determination has been made. Prior to the Company’s making such determination, the Company neither collected nor remitted these taxes, fees or surcharges to applicable local, municipal or state jurisdictions. The Company continues to analyze its activities to determine if it is subject to these taxes in additional jurisdictions and based on the Company’s ongoing assessment of its U.S. state and local tax collection and remittance obligations, the Company registers for tax and regulatory purposes in such jurisdictions and commences collecting and remitting applicable state and local taxes and surcharges to these jurisdictions.
As of December 31, 2024 and 2023, the Company had total accrued liabilities of $1.1 million and $1.7 million, respectively, for such contingent sales taxes and surcharges that were not being collected from its customers but may be imposed by various taxing authorities, of which $0.9 million and $0.8 million, respectively, were included in Accrued and other current liabilities on the consolidated balance sheets, and the remaining were included in Other long-term liabilities on the consolidated balance sheets. The Company’s estimate of the probable loss incurred under this contingency is based on its analysis of the source location of its usage-based fees and the regulations and rules in each tax jurisdiction.
Legal Matters
The Company is involved in various legal and regulatory matters arising in the normal course of business. In management’s opinion, resolution of these matters is not expected to have a material impact on the Company’s consolidated results of operations, cash flows, or its financial position. However, due to the uncertain nature of legal matters, an unfavorable resolution of a matter could materially affect the Company’s future consolidated results of operations, cash flows or financial position in a particular period. The Company expenses legal fees as incurred. The Company is currently party to the following action:
On December 4, 2024, a purported holder of the Company’s securities filed a putative class action complaint against the Company, its Chief Executive Officer, and its Chief Financial Officer in the United States District Court for the Northern District of California alleging violations of Section 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, promulgated thereunder, based on alleged false and/or misleading statements or omissions regarding the Company and its business and seeking unspecified damages on behalf of all persons and entities (subject to specified exceptions) that purchased or otherwise acquired the Company’s securities, including call options, from June 4, 2024, through the close of trading on August 8, 2024. On February 3, 2025, Lucid Alternative Fund, LP moved to be appointed lead plaintiff of this action pursuant to the Private Securities Litigation Reform Act of 1995. The Company cannot predict the duration or outcome of this lawsuit at this time. As a result, the Company is unable to estimate the reasonably possible loss or range of reasonably possible losses arising from this lawsuit. The Company intends to vigorously defend this lawsuit.
Indemnification Agreements
In the ordinary course of business, the Company enters into agreements of varying scope and terms pursuant to which it agrees to indemnify customers, vendors, lessors, business partners and other parties with respect to certain matters, including losses arising out of breach of such agreements, including breach of security, services to be provided by the Company or from intellectual property infringement claims made by third parties. The Company has received indemnification demands, and will likely continue to receive demands, from customers regarding its intellectual property indemnification obligations under these contracts. In addition, the Company has entered into indemnification agreements with its directors, officers and certain employees that requires it, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers or employees. There are no claims that the Company is aware of that could have a material effect on the consolidated balance sheets, consolidated statements of operations and comprehensive loss, or consolidated statements of cash flows.
- Segment and Geographical Information
The Company has a single operating and reportable segment and manages its business activities on a consolidated basis. The Company’s single segment provides its solution through a SaaS business model. The Company generates subscription revenue from its Intelligent CX Platform, and also generates usage-based telephony revenue. The Company charges its customers monthly subscription fees for access to its solution, primarily based on the number of licenses. The Company’s AI solutions are sold to its customers on a consumption or capacity basis. The Company’s reliable, secure, and scalable Intelligent CX Platform, powered by Five9 Genius AI, delivers a comprehensive suite of easy-to-use applications that enable the breadth of customer service, sales, and marketing related functions. The Company’s chief operating decision maker (“CODM”) is its chief executive officer. The Company’s CODM reviews financial information presented on a consolidated basis for purposes of assessing financial performance and making operating decisions on how to allocate resources based on net income (loss) that is also reported on its consolidated statements of operations and comprehensive loss as consolidated net income (loss). The measure of segment assets is reported on its consolidated balance sheets as total consolidated assets.
Revenue by Geographic Areas
The following table summarizes revenues by geographic region based on customer billing address (in thousands):
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| United States | $927,788 | $812,708 | $702,206 |
| International | 114,150 | 97,780 | 76,640 |
| Total revenue | $1,041,938 | $910,488 | $778,846 |
Long-Lived Assets, Net by Geographic Areas
The following table summarizes total property and equipment, net in the respective locations (in thousands):
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| United States | $136,382 | $101,567 |
| International | 8,506 | 7,005 |
| Property and equipment, net | $144,888 | $108,572 |
Total purchases of property and equipment for the years ended December 31, 2024, 2023 and 2022 are disclosed in the Company’s Consolidated Statements of Cash Flows.
Segment Information - Consolidated Statement of Operations
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Revenue | $1,041,938 | $910,488 | $778,846 |
| Adjusted cost of revenue(1) | (399,197) | (354,729) | (301,661) |
| Adjusted research and development(2) | (122,053) | (99,418) | (83,337) |
| Adjusted sales and marketing(3) | (256,193) | (230,419) | (202,617) |
| Adjusted general and administrative(4) | (68,513) | (59,657) | (50,795) |
| Other segment items(5) | (194,380) | (216,326) | (183,347) |
| Depreciation and amortization | (52,905) | (48,515) | (44,671) |
| Interest expense | (14,812) | (7,646) | (7,493) |
| Gain on early extinguishment of debt | 6,615 | — | — |
| Interest income and other | 46,745 | 26,799 | 4,813 |
| Provision for income taxes | (40) | (2,341) | (4,388) |
| Net loss | $(12,795) | $(81,764) | $(94,650) |
(1) Adjusted cost of revenue includes cost of revenue in accordance with GAAP adjusted for depreciation and amortization, stock-based compensation, exit costs related to the closure and relocation of the Company’s Russian operations, acquisition and related transaction costs and one-time integration costs, lease amortization for finance leases, costs related to a reduction in force plan, and refund for prior year overpayment of USF fees.
(2) Adjusted research and development includes research and development in accordance with GAAP adjusted for depreciation and amortization, stock-based compensation, exit costs related to the closure and relocation of the
Company’s Russian operations, acquisition and related transaction costs and one-time integration costs, and costs related to a reduction in force plan.
(3) Adjusted sales and marketing includes sales and marketing expense in accordance with GAAP adjusted for depreciation and amortization, stock-based compensation, acquisition and related transaction costs and one-time integration costs, and costs related to a reduction in force plan.
(4) Adjusted general and administrative included general and administrative expense in accordance with GAAP adjusted for depreciation and amortization, stock-based compensation, exit costs related to the closure and relocation of the Company’s Russian operations, acquisition and related transaction costs and one-time integration costs, costs related to a reduction in force plan, impairment charge related to closure of operating lease facilities, and contingent consideration expense.
(5)Other segment items included in segment net loss includes stock-based compensation, exit costs related to the closure and relocation of our Russian operations, acquisition and related transaction costs and one-time integration costs, lease amortization for finance leases, costs related to a reduction in force plan, and impairment charge related to closure of operating lease facilities.
- Retirement Plans
The Company has a 401(k) plan to provide tax deferred salary deductions for all eligible employees. Participants may make voluntary contributions to the 401(k) plan, limited by certain Internal Revenue Service restrictions. The Company is responsible for the administrative costs of the 401(k) plan. The Company began matching employee contributions in cash in the fourth quarter of 2019. The contribution expense for the years ended December 31, 2024, 2023 and 2022 was $2.7 million, $2.4 million and $2.1 million, respectively.
The Company complies with the requirement of maintaining a retirement plan for employees in the Philippines. This plan is a non-contributory and defined benefit plan that provides retirement to employees equal to approximately one month salary for every year of credited service for employees who attain the normal retirement age of 60 with at least five years of service. The benefits are paid in a lump sum amount upon retirement from the Company. Total defined benefit liability under this plan was $1.1 million and $0.8 million as of each of December 31, 2024 and 2023, respectively. Total retirement expense for this plan were $0.3 million, $0.3 million, and $0.2 million for the years ended December 31, 2024, 2023, and 2022, respectively.
- Leases
The Company has leases for offices, data centers and computer and networking equipment that expire at various dates through 2031. The Company’s leases have remaining terms ofone toseven years, some of the leases include a Company option to extend the leases for up toone tofive years, and some of the leases include the option to terminate the leases upon 30-days’ notice. The Company does not separate lease and non-lease components for real estate operating leases.
As the Company’s leases do not provide an implicit rate, the net present value of future minimum lease payments is determined using the Company’s incremental borrowing rate. Operating leases with a duration of 12 months or less are excluded from right-of-use assets and operating lease liabilities, and related lease payments are generally recognized on a straight-line basis over the lease term and variable lease payments are recognized as incurred.
The Company entered into three-year equipment finance lease agreements and recognized $18.6 million right of use assets during 2024, which were reported within Finance lease right-of-use assets on the consolidated balance sheets and are being depreciated on a straight-line basis over the lease term. As a result, the Company also recognized short-term lease liabilities of $5.9 million within Finance lease liabilities and long-term lease liabilities of $12.7 million within Finance lease liabilities - less current portion on the consolidated balance sheets for the year ended December 31, 2024.
The components of lease expenses were as follows (in thousands):
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Operating lease cost | $13,270 | $13,544 | $12,072 |
| Finance lease cost: | |||
| Amortization of right-of-use assets | $3,857 | $940 | $56 |
| Interest on finance lease liabilities | 552 | 155 | — |
| Total finance lease cost | $4,409 | $1,095 | $56 |
Supplemental cash flow information related to leases was as follows (in thousands):
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Cash paid for amounts included in the measurement of lease liabilities: | |||
| Operating cash used in operating leases | $(12,259) | $(10,966) | $(11,684) |
| Financing cash used in finance leases | (4,012) | (989) | — |
| Right of use assets obtained in exchange for lease obligations: | |||
| Operating leases | 9,448 | 6,454 | 5,984 |
| Finance leases | 18,559 | 5,505 | — |
Supplemental balance sheet information related to leases was as follows (in thousands):
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Operating leases | ||
| Operating lease right-of-use assets | $38,880 | $38,873 |
| Operating lease liabilities | $11,258 | $10,731 |
| Operating lease liabilities — less current portion | 37,071 | 36,378 |
| Total operating lease liabilities | $48,329 | $47,109 |
| Finance leases | ||
| Finance lease right-of-use assets | $19,269 | $4,564 |
| Property and equipment, gross | $21,708 | $29,503 |
| Less: accumulated depreciation and amortization | (21,708) | (29,503) |
| Property and equipment, net | $— | $— |
| Finance lease liabilities | $7,768 | $1,767 |
| Finance lease liabilities — less current portion | 11,688 | 2,877 |
| Total finance lease liabilities | $19,456 | $4,644 |
During 2024, the Company recognized a $1.9 million impairment loss as a result of its commitment to closetwo operating lease facilities and a $0.3 million impairment loss related to the associated leasehold improvements and property and equipment.
Weighted average remaining terms were as follows (in years):
| December 31, | ||
| 2024 | 2023 | |
| Weighted average remaining lease term | ||
|---|---|---|
| Operating leases | 5.0 years | 5.7 years |
| Finance leases | 2.5 years | 2.6 years |
Weighted average discount rates were as follows:
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Weighted average discount rate | ||
| Operating leases | 4.2% | 3.8% |
| Finance leases | 5.8% | 6.1% |
Maturities of lease liabilities were as follows (in thousands):
| Year Ending December 31, | Operating Leases | Finance Leases |
|---|---|---|
| 2025 | $12,898 | $8,643 |
| 2026 | 10,997 | 7,692 |
| 2027 | 8,142 | 4,502 |
| 2028 | 6,837 | — |
| 2029 | 6,824 | — |
| Thereafter | 7,596 | — |
| Total future minimum lease payments | 53,294 | 20,837 |
| Less: imputed interest | (4,965) | (1,381) |
| Total | $48,329 | $19,456 |
- Acquisitions
Acqueon
On August 27, 2024, the Company acquired all of the issued and outstanding shares of capital stock of Acqueon for total consideration of approximately $173.8 million. This acquisition, which was accounted for as a business combination, is intended to build on the pre-existing partnership between the companies, and to extend the Company's AI-powered CX platform by adding omnichannel proactive customer engagement to expand the Company’s outbound capabilities.
The excess of the purchase price over identifiable intangible assets and net tangible assets in the amount of $138.2 million was allocated to goodwill, which is not deductible for tax purposes. The fair values assigned to assets acquired and liabilities assumed are based on management’s best estimates and assumptions as of the acquisition date and are considered preliminary pending finalization of valuation analyses pertaining to intangible assets acquired, liabilities assumed and tax liabilities assumed. During the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments to the fair value of these tangible and intangible assets acquired and liabilities assumed, with the corresponding offset to goodwill. The Company recorded an adjustment of less than $0.1 million during the one year from acquisition date measurement period for the year ended December 31, 2024. The following table presents the preliminary allocation of the purchase price at the acquisition date (in thousands):
| Cash | $6,661 |
|---|---|
| Tangible assets acquired | 4,580 |
| Other assets acquired | 7,333 |
| Acquired technology | 30,400 |
| Customer relationships | 8,700 |
| Trademarks | 800 |
| Goodwill | 138,167 |
| Total assets acquired | 196,641 |
| Deferred tax liability | (4,817) |
| Liabilities assumed | (17,997) |
| Total | $173,827 |
The acquired technology, customer relationships, and trademarks will be amortized on a straight-line basis over their estimated useful lives ofeight years, five years, andthree years, respectively. The Company used the income approach to estimate the fair value of intangible assets acquired.
In connection with this acquisition, the Company incurred total acquisition-related transaction costs of $7.9 million during the year ended December 31, 2024, which were expensed as incurred and included in general and administrative expenses in the consolidated statements of operations and comprehensive loss.
The results of operations of this acquisition are included in the accompanying consolidated statements of operations and comprehensive loss from the date of acquisition and are not material to the Company's consolidated financial statements.
Aceyus
On August 14, 2023, the Company acquired all of the issued and outstanding shares of capital stock of Aceyus for total cash consideration of approximately $82.0 million. This acquisition, which was accounted for as a business combination, is intended to accelerate the Company's ability to capitalize on two business opportunities, namely facilitating the migration of large enterprise customers from on-premises to cloud and leveraging contextual data to deliver personalized experiences throughout the customer journey, including using this contextual data in the Company's AI & Automation solutions.
The excess of the purchase price over identifiable intangible assets and net tangible assets in the amount of $61.8 million was allocated to goodwill, which is not deductible for tax purposes. The fair values assigned to assets acquired and liabilities assumed were based on management’s best estimates and assumptions as of the reporting date and are considered final. The Company recorded an adjustment of $0.1 million during the one year from acquisition date measurement period for the year ended December 31, 2024. The following table presents the final allocation of the purchase price at the acquisition date (in thousands):
| Cash | $1,523 |
|---|---|
| Tangible assets acquired | 383 |
| Other assets acquired | 3,002 |
| Acquired technology | 19,100 |
| Customer relationships | 2,550 |
| Trademarks | 500 |
| Goodwill | 61,849 |
| Total assets acquired | 88,907 |
| Liabilities assumed | (6,895) |
| Total | $82,012 |
The acquired technology, customer relationships, and trademarks will be amortized on a straight-line basis over their estimated useful lives ofeight years, five years, andthree years, respectively. The Company used the income approach to estimate the fair value of intangible assets acquired.
In connection with this acquisition, the Company incurred total acquisition-related transaction costs of $2.2 million during the year ended December 31, 2023, and incurred no additional costs during the year ended December 31, 2024, which were expensed as incurred and included in general and administrative expenses in the consolidated statements of operations and comprehensive loss.
The results of operations of this acquisition are included in the accompanying consolidated statements of operations and comprehensive loss from the date of acquisition and are not material to the Company's consolidated financial statements.
- Restructuring
On August 20, 2024, the Company announced a reduction in force plan (the “Plan”) as part of its broader efforts to drive balanced, profitable growth, further supporting its positive, long-term outlook and focus on increasing shareholder value. The Plan reduced the Company’s global full-time employees by approximately 6%. For the year ended December 31, 2024, the Company incurred a total of $9.6 million in restructuring costs under the Plan, primarily consisting of notice period payments, severance payments, employee benefits and related costs, all of which are cash expenditures, of which $2.1 million was recorded incost of revenue, $1.9 million was recorded inresearch and development expenses, $4.4 million was recorded insales and marketing expenses, and $1.2 million was recorded ingeneral and administrative expenses on the consolidated statements of operations and comprehensive loss. As of December 31, 2024, $9.3 million had been paid and the remaining $0.3 million was recorded within Accrued and other current liabilities in the consolidated balance sheets and is mostly expected to be paid by the first quarter of 2025. Other than as set forth herein, the Company doesnot expect to incur any additional costs under the Plan.
- Selected Quarterly Financial Data (Unaudited)
Selected quarterly financial information for 2024 and 2023 is as follows:
| Quarter Ended | ||||||||
|---|---|---|---|---|---|---|---|---|
| Dec. 31, 2024 | Sept. 30, 2024 | Jun. 30, 2024 | Mar. 31, 2024 | Dec. 31, 2023 | Sept. 30, 2023 | Jun. 30, 2023 | Mar. 31, 2023 | |
| (unaudited, in thousands, except per share data) | ||||||||
| Revenue | $278,660 | $264,182 | $252,086 | $247,010 | $239,062 | $230,105 | $222,882 | $218,439 |
| Cost of revenue (1)(2) | 122,663 | 121,933 | 118,414 | 114,530 | 112,493 | 111,080 | 104,361 | 104,756 |
| Gross profit | 155,997 | 142,249 | 133,672 | 132,480 | 126,569 | 119,025 | 118,521 | 113,683 |
| Operating expenses: | ||||||||
| Research and development (1)(2) | 41,480 | 42,482 | 40,717 | 41,518 | 38,873 | 40,391 | 39,210 | 38,108 |
| Sales and marketing (1)(2) | 73,898 | 78,615 | 78,332 | 81,109 | 72,956 | 73,366 | 74,077 | 76,314 |
| General and administrative (1)(2) | 36,439 | 36,575 | 33,988 | 30,548 | 33,338 | 31,006 | 30,477 | 28,258 |
| Total operating expenses | 151,817 | 157,672 | 153,037 | 153,175 | 145,167 | 144,763 | 143,764 | 142,680 |
| Income (loss) from operations | 4,180 | (15,423) | (19,365) | (20,695) | (18,598) | (25,738) | (25,243) | (28,997) |
| Other (expense) income, net: | ||||||||
| Interest expense | (4,271) | (4,068) | (3,906) | (2,567) | (1,963) | (1,972) | (1,866) | (1,845) |
| Gain on early extinguishment of debt | — | — | — | 6,615 | — | — | — | — |
| Interest income and other | 11,242 | 11,144 | 13,800 | 10,559 | 8,322 | 8,233 | 6,123 | 4,121 |
| Total other income (expense), net | 6,971 | 7,076 | 9,894 | 14,607 | 6,359 | 6,261 | 4,257 | 2,276 |
| Income (loss) before income taxes | 11,151 | (8,347) | (9,471) | (6,088) | (12,239) | (19,477) | (20,986) | (26,721) |
| Provision for (benefit from) income taxes | (426) | (3,868) | 3,345 | 989 | 119 | 942 | 753 | 527 |
| Net income (loss) | $11,577 | $(4,479) | $(12,816) | $(7,077) | $(12,358) | $(20,419) | $(21,739) | $(27,248) |
| Net income (loss) per share: | ||||||||
| Basic | $0.15 | $(0.06) | $(0.17) | $(0.10) | $(0.17) | $(0.28) | $(0.30) | $(0.38) |
| Diluted | $0.13 | $(0.06) | $(0.17) | $(0.10) | $(0.17) | $(0.28) | $(0.30) | $(0.38) |
| Shares used in computing net income (loss) per share: | ||||||||
| Basic | 75,430 | 74,876 | 74,203 | 73,488 | 72,926 | 72,356 | 71,627 | 71,259 |
| Diluted | 88,645 | 74,876 | 74,203 | 73,488 | 72,926 | 72,356 | 71,627 | 71,259 |
(1) Included stock-based compensation as follows:
| Quarter Ended | ||||||||
|---|---|---|---|---|---|---|---|---|
| Dec. 31, 2024 | Sept. 30, 2024 | Jun. 30, 2024 | Mar. 31, 2024 | Dec. 31, 2023 | Sept. 30, 2023 | Jun. 30, 2023 | Mar. 31, 2023 | |
| (unaudited, in thousands) | ||||||||
| Cost of revenue | $6,921 | $7,512 | $7,789 | $7,603 | $9,182 | $9,856 | $9,888 | $9,333 |
| Research and development | 8,259 | 8,244 | 9,827 | 10,930 | 12,055 | 12,980 | 13,013 | 12,382 |
| Sales and marketing | 10,880 | 12,490 | 13,824 | 14,020 | 15,389 | 16,404 | 17,391 | 17,045 |
| General and administrative | 12,383 | 11,310 | 12,192 | 12,131 | 12,945 | 13,371 | 13,075 | 11,983 |
| Total stock-based compensation | $38,443 | $39,556 | $43,632 | $44,684 | $49,571 | $52,611 | $53,367 | $50,743 |
(2) Included depreciation and amortization expenses as follows:
| Quarter Ended | ||||||||
|---|---|---|---|---|---|---|---|---|
| Dec. 31, 2024 | Sept. 30, 2024 | Jun. 30, 2024 | Mar. 31, 2024 | Dec. 31, 2023 | Sept. 30, 2023 | Jun. 30, 2023 | Mar. 31, 2023 | |
| (unaudited, in thousands) | ||||||||
| Cost of revenue | $12,087 | $10,414 | $10,421 | $9,613 | $10,308 | $10,075 | $9,269 | $8,907 |
| Research and development | 620 | 721 | 741 | 890 | 1,012 | 831 | 868 | 872 |
| Sales and marketing | 38 | 32 | 26 | 27 | 27 | 36 | 1 | 1 |
| General and administrative | 1,895 | 1,977 | 1,750 | 1,653 | 1,615 | 1,540 | 1,586 | 1,567 |
| Total depreciation and amortization | $14,640 | $13,144 | $12,938 | $12,183 | $12,962 | $12,482 | $11,724 | $11,347 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.